| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | dipeptidyl-peptidase activity | 2.67e-05 | 12 | 101 | 3 | GO:0008239 | |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor activity | 1.80e-04 | 22 | 101 | 3 | GO:0004993 | |
| GeneOntologyCellularComponent | pericentriolar material | 1.00e-05 | 28 | 102 | 4 | GO:0000242 | |
| Domain | - | 3.03e-06 | 6 | 101 | 3 | 2.140.10.30 | |
| Domain | DPPIV_N | 3.03e-06 | 6 | 101 | 3 | PF00930 | |
| Domain | Peptidase_S9B_N | 3.03e-06 | 6 | 101 | 3 | IPR002469 | |
| Domain | Peptidase_S9 | 2.45e-05 | 11 | 101 | 3 | PF00326 | |
| Domain | Peptidase_S9 | 2.45e-05 | 11 | 101 | 3 | IPR001375 | |
| Domain | Gamma_tubulin | 2.90e-05 | 2 | 101 | 2 | IPR002454 | |
| Domain | ATPASE_C | 8.66e-05 | 3 | 101 | 2 | PS00605 | |
| Domain | ATP_synth_F0_csu_DDCD_BS | 8.66e-05 | 3 | 101 | 2 | IPR020537 | |
| Domain | - | 8.66e-05 | 3 | 101 | 2 | 1.20.20.10 | |
| Domain | ATP_synth_F0_csu | 1.73e-04 | 4 | 101 | 2 | IPR000454 | |
| Domain | Quinoprotein_ADH-like_supfam | 1.92e-04 | 53 | 101 | 4 | IPR011047 | |
| Domain | ATP-synt_C | 2.86e-04 | 5 | 101 | 2 | PF00137 | |
| Domain | ATPase_proteolipid_c-like_dom | 2.86e-04 | 5 | 101 | 2 | IPR002379 | |
| Domain | - | 4.70e-04 | 119 | 101 | 5 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 4.70e-04 | 119 | 101 | 5 | IPR029058 | |
| Domain | LRR | 7.83e-04 | 201 | 101 | 6 | PS51450 | |
| Domain | Sel1 | 7.94e-04 | 8 | 101 | 2 | PF08238 | |
| Domain | SEL1 | 7.94e-04 | 8 | 101 | 2 | SM00671 | |
| Domain | Sel1-like | 1.02e-03 | 9 | 101 | 2 | IPR006597 | |
| Domain | 5HT_rcpt | 1.02e-03 | 9 | 101 | 2 | IPR002231 | |
| Domain | LRR_1 | 1.22e-03 | 219 | 101 | 6 | PF00560 | |
| Domain | STAS | 1.54e-03 | 11 | 101 | 2 | PS50801 | |
| Domain | STAS_dom | 1.54e-03 | 11 | 101 | 2 | IPR002645 | |
| Domain | SLC26A/SulP_dom | 1.54e-03 | 11 | 101 | 2 | IPR011547 | |
| Domain | STAS | 1.54e-03 | 11 | 101 | 2 | PF01740 | |
| Domain | SLC26A/SulP_fam | 1.54e-03 | 11 | 101 | 2 | IPR001902 | |
| Domain | - | 1.54e-03 | 11 | 101 | 2 | 3.30.750.24 | |
| Domain | Sulfate_transp | 1.54e-03 | 11 | 101 | 2 | PF00916 | |
| Domain | - | 1.80e-03 | 321 | 101 | 7 | 3.80.10.10 | |
| Domain | ABC_A | 1.84e-03 | 12 | 101 | 2 | IPR026082 | |
| Domain | L_dom-like | 2.03e-03 | 328 | 101 | 7 | IPR032675 | |
| Domain | LRR_8 | 2.37e-03 | 171 | 101 | 5 | PF13855 | |
| Domain | 7TM_GPCR_Srsx | 3.20e-03 | 112 | 101 | 4 | SM01381 | |
| Domain | Leu-rich_rpt | 3.54e-03 | 271 | 101 | 6 | IPR001611 | |
| Domain | - | 5.16e-03 | 20 | 101 | 2 | 3.30.1330.20 | |
| Domain | - | 5.34e-03 | 207 | 101 | 5 | 1.25.40.10 | |
| Domain | - | 5.69e-03 | 21 | 101 | 2 | 1.10.287.600 | |
| Domain | Tubulin_C | 6.23e-03 | 22 | 101 | 2 | SM00865 | |
| Domain | Tubulin_C | 6.23e-03 | 22 | 101 | 2 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 6.23e-03 | 22 | 101 | 2 | IPR018316 | |
| Domain | - | 6.23e-03 | 22 | 101 | 2 | 3.40.50.1440 | |
| Domain | Tubulin_C | 6.80e-03 | 23 | 101 | 2 | IPR023123 | |
| Domain | TUBULIN | 6.80e-03 | 23 | 101 | 2 | PS00227 | |
| Domain | Tubulin | 6.80e-03 | 23 | 101 | 2 | IPR000217 | |
| Domain | Tub_FtsZ_C | 6.80e-03 | 23 | 101 | 2 | IPR008280 | |
| Domain | Tubulin | 6.80e-03 | 23 | 101 | 2 | SM00864 | |
| Domain | Tubulin_CS | 6.80e-03 | 23 | 101 | 2 | IPR017975 | |
| Pubmed | 3.51e-06 | 306 | 102 | 8 | 18973680 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | SEL1L VRK2 AHCTF1 HSPH1 DNAJC18 APLP2 TMEM214 HACD2 TUBG1 STT3A ANAPC2 DDX20 PLOD1 | 3.94e-06 | 942 | 102 | 13 | 31073040 |
| Pubmed | 3.97e-06 | 11 | 102 | 3 | 10352232 | ||
| Pubmed | 5.29e-06 | 12 | 102 | 3 | 28069795 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | OGT TMEM237 MCM4 CRTC1 APLP2 HACD2 SHOC2 CTSA TUBG1 EIF3CL CNOT6 BUB1 DDX20 SNAPC1 FGD6 | 7.18e-06 | 1321 | 102 | 15 | 27173435 |
| Pubmed | Identification of a region within SEL1L protein required for tumour growth inhibition. | 8.52e-06 | 2 | 102 | 2 | 14729273 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 28119396 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 18715570 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 27732084 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 30056125 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 21262467 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 20138207 | ||
| Pubmed | MTOC reorientation occurs during FcgammaR-mediated phagocytosis in macrophages. | 8.52e-06 | 2 | 102 | 2 | 17442887 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 29548885 | ||
| Pubmed | HTR2C and HTR1A gene variants in German and Italian suicide attempters and completers. | 8.52e-06 | 2 | 102 | 2 | 17192951 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 10444334 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 22806905 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 33075816 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 15362044 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 8485160 | ||
| Pubmed | Gene knockout analysis of two gamma-tubulin isoforms in mice. | 8.52e-06 | 2 | 102 | 2 | 15893303 | |
| Pubmed | RABL2 positively controls localization of GPCRs in mammalian primary cilia. | 8.52e-06 | 2 | 102 | 2 | 30578315 | |
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 17287496 | ||
| Pubmed | 8.52e-06 | 2 | 102 | 2 | 34705256 | ||
| Pubmed | Novel Mechanism of Cholesterol Transport by ABCA5 in Macrophages and Its Role in Dyslipidemia. | 8.52e-06 | 2 | 102 | 2 | 32687853 | |
| Pubmed | 1.33e-05 | 16 | 102 | 3 | 18272593 | ||
| Pubmed | 2.29e-05 | 19 | 102 | 3 | 22698544 | ||
| Pubmed | 2.29e-05 | 19 | 102 | 3 | 29166577 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 10903841 | ||
| Pubmed | Positive association between panic disorder and polymorphism of the serotonin 2A receptor gene. | 2.55e-05 | 3 | 102 | 2 | 12759158 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 28289229 | ||
| Pubmed | Blastocyst H(2) receptor is the target for uterine histamine in implantation in the mouse. | 2.55e-05 | 3 | 102 | 2 | 10821762 | |
| Pubmed | Serotonin receptors, novel targets of sulforaphane identified by proteomic analysis in Caco-2 cells. | 2.55e-05 | 3 | 102 | 2 | 18593952 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 18227221 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 19008301 | ||
| Pubmed | Cutting edge: histamine is required for IL-4-driven eosinophilic allergic responses. | 2.55e-05 | 3 | 102 | 2 | 22156496 | |
| Pubmed | Human TUBG2 gene is expressed as two splice variant mRNA and involved in cell growth. | 2.55e-05 | 3 | 102 | 2 | 27015882 | |
| Pubmed | Characterization of the human homologue of the yeast spc98p and its association with gamma-tubulin. | 2.55e-05 | 3 | 102 | 2 | 9566969 | |
| Pubmed | Regulation of APC/C activity in oocytes by a Bub1-dependent spindle assembly checkpoint. | 2.55e-05 | 3 | 102 | 2 | 19249208 | |
| Pubmed | The Aurora A-HP1γ pathway regulates gene expression and mitosis in cells from the sperm lineage. | 2.55e-05 | 3 | 102 | 2 | 26021315 | |
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 19762454 | ||
| Pubmed | 2.55e-05 | 3 | 102 | 2 | 29709878 | ||
| Pubmed | 2.69e-05 | 20 | 102 | 3 | 21045211 | ||
| Pubmed | 2.69e-05 | 20 | 102 | 3 | 30927234 | ||
| Pubmed | 3.13e-05 | 21 | 102 | 3 | 22935613 | ||
| Pubmed | 3.13e-05 | 21 | 102 | 3 | 22007132 | ||
| Pubmed | 3.13e-05 | 21 | 102 | 3 | 29487191 | ||
| Pubmed | Broad-minded links cell cycle-related kinase to cilia assembly and hedgehog signal transduction. | 3.62e-05 | 22 | 102 | 3 | 20159594 | |
| Pubmed | Primary cilia regulate hippocampal neurogenesis by mediating sonic hedgehog signaling. | 4.16e-05 | 23 | 102 | 3 | 18728187 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | SEL1L MBTPS1 HSPH1 DNAJC18 APLP2 TMEM214 HACD2 CTSA STT3A FAP PTPRS LOX PLOD1 | 5.05e-05 | 1201 | 102 | 13 | 35696571 |
| Pubmed | Sequences of members of the human gene family for the c subunit of mitochondrial ATP synthase. | 5.09e-05 | 4 | 102 | 2 | 8328972 | |
| Pubmed | Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas. | 5.09e-05 | 4 | 102 | 2 | 20043068 | |
| Pubmed | Loss of Necdin impairs myosin activation and delays cell polarization. | 5.09e-05 | 4 | 102 | 2 | 20665884 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 20164345 | ||
| Pubmed | Emerging links between initiation of translation and human diseases. | 5.09e-05 | 4 | 102 | 2 | 12226704 | |
| Pubmed | Piezo mechanosensory channels regulate centrosome integrity and mitotic entry. | 5.09e-05 | 4 | 102 | 2 | 36574677 | |
| Pubmed | 5-HT2A and 5-HT2C receptors and their atypical regulation properties. | 5.09e-05 | 4 | 102 | 2 | 12650852 | |
| Pubmed | Profiles of serotonin receptors in the developing human thalamus. | 5.09e-05 | 4 | 102 | 2 | 20538346 | |
| Pubmed | Sequence analysis and mapping of a novel human mitochondrial ATP synthase subunit 9 cDNA (ATP5G3). | 5.09e-05 | 4 | 102 | 2 | 7698763 | |
| Pubmed | The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders. | 5.09e-05 | 4 | 102 | 2 | 17288995 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 33404706 | ||
| Pubmed | Aspm specifically maintains symmetric proliferative divisions of neuroepithelial cells. | 5.09e-05 | 4 | 102 | 2 | 16798874 | |
| Pubmed | TrkA mediates retrograde semaphorin 3A signaling through plexin A4 to regulate dendritic branching. | 5.09e-05 | 4 | 102 | 2 | 26945060 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 10799679 | ||
| Pubmed | Human liver cDNA clones encoding proteolipid subunit 9 of the mitochondrial ATPase complex. | 5.09e-05 | 4 | 102 | 2 | 2883974 | |
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 11567631 | ||
| Pubmed | 5.09e-05 | 4 | 102 | 2 | 29198940 | ||
| Pubmed | A genetic variant of HTR2C may play a role in the manifestation of Tourette syndrome. | 5.09e-05 | 4 | 102 | 2 | 20010450 | |
| Pubmed | 7.61e-05 | 28 | 102 | 3 | 26884322 | ||
| Pubmed | The small GTPase RSG1 controls a final step in primary cilia initiation. | 7.61e-05 | 28 | 102 | 3 | 29038301 | |
| Pubmed | 8.28e-05 | 613 | 102 | 9 | 22268729 | ||
| Pubmed | Primary cilia dynamics instruct tissue patterning and repair of corneal endothelium. | 8.47e-05 | 5 | 102 | 2 | 21285373 | |
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 29244804 | ||
| Pubmed | Mutations in the Heterotopia Gene Eml1/EML1 Severely Disrupt the Formation of Primary Cilia. | 8.47e-05 | 5 | 102 | 2 | 31390572 | |
| Pubmed | Rabl2 GTP hydrolysis licenses BBSome-mediated export to fine-tune ciliary signaling. | 8.47e-05 | 5 | 102 | 2 | 33241915 | |
| Pubmed | A two-kinesin mechanism controls neurogenesis in the developing brain. | 8.47e-05 | 5 | 102 | 2 | 38040957 | |
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 16751367 | ||
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 8833759 | ||
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 15680357 | ||
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 18663369 | ||
| Pubmed | Evolutionary analysis of a cluster of ATP-binding cassette (ABC) genes. | 8.47e-05 | 5 | 102 | 2 | 12532264 | |
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 25453842 | ||
| Pubmed | Epilepsy and serotonin (5HT): variations of 5HT-related genes in temporal lobe epilepsy. | 8.47e-05 | 5 | 102 | 2 | 20435093 | |
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 19251731 | ||
| Pubmed | The essential role of centrosomal NDE1 in human cerebral cortex neurogenesis. | 8.47e-05 | 5 | 102 | 2 | 21529752 | |
| Pubmed | Monocilia in the embryonic mouse heart suggest a direct role for cilia in cardiac morphogenesis. | 8.47e-05 | 5 | 102 | 2 | 18729223 | |
| Pubmed | Regulation of dipeptidyl peptidase 8 and 9 expression in activated lymphocytes and injured liver. | 8.47e-05 | 5 | 102 | 2 | 23704821 | |
| Pubmed | WDR62 is associated with the spindle pole and is mutated in human microcephaly. | 8.47e-05 | 5 | 102 | 2 | 20890279 | |
| Pubmed | Speriolin is a novel human and mouse sperm centrosome protein. | 8.47e-05 | 5 | 102 | 2 | 20542897 | |
| Pubmed | 8.47e-05 | 5 | 102 | 2 | 25877302 | ||
| Pubmed | HIV-1 Vpr induces defects in mitosis, cytokinesis, nuclear structure, and centrosomes. | 8.47e-05 | 5 | 102 | 2 | 14767062 | |
| Pubmed | 1.25e-04 | 33 | 102 | 3 | 30914320 | ||
| Pubmed | 1.27e-04 | 6 | 102 | 2 | 16770336 | ||
| Pubmed | 1.27e-04 | 6 | 102 | 2 | 38546045 | ||
| Pubmed | 1.27e-04 | 6 | 102 | 2 | 30970247 | ||
| Pubmed | 1.27e-04 | 6 | 102 | 2 | 35259752 | ||
| Pubmed | DOCK7 interacts with TACC3 to regulate interkinetic nuclear migration and cortical neurogenesis. | 1.27e-04 | 6 | 102 | 2 | 22842144 | |
| Pubmed | Cytoplasmic Cl- couples membrane remodeling to epithelial morphogenesis. | 1.27e-04 | 6 | 102 | 2 | 29229864 | |
| Pubmed | 1.27e-04 | 6 | 102 | 2 | 10840040 | ||
| Pubmed | 1.27e-04 | 6 | 102 | 2 | 36334595 | ||
| Cytoband | 2q14 | 2.65e-04 | 11 | 102 | 2 | 2q14 | |
| GeneFamily | CD molecules|DASH family | 2.37e-06 | 7 | 75 | 3 | 1205 | |
| GeneFamily | RAB like GTPases | 1.68e-04 | 5 | 75 | 2 | 394 | |
| GeneFamily | 5-hydroxytryptamine receptors, G protein-coupled | 1.29e-03 | 13 | 75 | 2 | 170 | |
| GeneFamily | ATP binding cassette subfamily A | 1.50e-03 | 14 | 75 | 2 | 805 | |
| GeneFamily | F-type ATPases|Mitochondrial complex V: ATP synthase subunits | 2.49e-03 | 18 | 75 | 2 | 416 | |
| GeneFamily | F-type ATPases|Mitochondrial complex V: ATP synthase subunits | 2.77e-03 | 19 | 75 | 2 | 644 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-06 | 156 | 102 | 6 | d5207dbfbcfb885557ea1378dfe6a56d7102e94a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-06 | 156 | 102 | 6 | 363f1b661048d25895e2b8681c82894c957b29c0 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.80e-06 | 159 | 102 | 6 | 7f29f9dcf25ffa1822b137c571e9ac16defc6292 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.74e-06 | 188 | 102 | 6 | b6aad90fa77fbaf80487a55415aa6c245f2d1f7e | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.89e-06 | 189 | 102 | 6 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.89e-06 | 189 | 102 | 6 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.04e-06 | 190 | 102 | 6 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.19e-06 | 191 | 102 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.19e-06 | 191 | 102 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.35e-06 | 192 | 102 | 6 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.35e-06 | 192 | 102 | 6 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.35e-06 | 192 | 102 | 6 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.35e-06 | 192 | 102 | 6 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.68e-06 | 194 | 102 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.57e-06 | 199 | 102 | 6 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3_(Neuron.Gad1Gad2.Cplx3)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.69e-06 | 53 | 102 | 4 | 9c6aba539d540211b2309da1af6a531f3275a49d | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3_(Neuron.Gad1Gad2.Cplx3)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.69e-06 | 53 | 102 | 4 | 846e031024ad3a4f5c6640b61cf4a0e69dbbcd1c | |
| ToppCell | COVID_vent|World / Disease condition, Lineage, Cell class and subclass | 6.76e-06 | 200 | 102 | 6 | 1d88e5cc4534073f27a7562e1c4b884bd67f09d9 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.71e-05 | 139 | 102 | 5 | 408bc31aa5e1c2b379f79198fe8b5411f8d7bd08 | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-plasma_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.79e-05 | 164 | 102 | 5 | b92e7c91910d518627376166c6ea9ed333b3d07e | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-plasma_cell-plasma_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.79e-05 | 164 | 102 | 5 | a1e43c6b3e2553f5604100db6e92bf244b70c36d | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-05 | 165 | 102 | 5 | 7c771f22b58989572c939ed127e637ec28dc0dca | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.13e-05 | 167 | 102 | 5 | 859dfe0764cb69de27e79e1c1aa65f9d538f79ea | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-Tuft|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.37e-05 | 169 | 102 | 5 | 05e12524d68d409fed386ffad233305683b4575b | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.76e-05 | 172 | 102 | 5 | f0e767a20d93e546ce278db67dbd779cc68af533 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.02e-05 | 174 | 102 | 5 | f520b79d277e286c9bb5d091e6c94e7ec7e46699 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.16e-05 | 175 | 102 | 5 | d983e80eeb11f341c564ea684e2b0b585a90ae58 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.16e-05 | 175 | 102 | 5 | 53e6f1f8dd482dfa2539e068dacefbb6e08443bc | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.45e-05 | 177 | 102 | 5 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.45e-05 | 177 | 102 | 5 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.60e-05 | 178 | 102 | 5 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | Control-Developping_Plasmablast|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.75e-05 | 179 | 102 | 5 | 9383568f78b07b8cca72ece5d15fea209aa54ea9 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.75e-05 | 179 | 102 | 5 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.75e-05 | 179 | 102 | 5 | fae869fb0a91428481bf8a9c111dcc639e2b4278 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.90e-05 | 180 | 102 | 5 | a600bc705993d3a010550a25d3b54358946f061f | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.06e-05 | 181 | 102 | 5 | 79102845baee5af583eec24e9f91dfec46ab7de3 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-M/X_cells_(MLN/GHRL+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.06e-05 | 181 | 102 | 5 | af031661af28f99d906d8e013b4949133b44a2e6 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.38e-05 | 183 | 102 | 5 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.38e-05 | 183 | 102 | 5 | 263937906ddabc798bbe60f0da28ba859a5c72e2 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.43e-05 | 189 | 102 | 5 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.43e-05 | 189 | 102 | 5 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.62e-05 | 190 | 102 | 5 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.62e-05 | 190 | 102 | 5 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 7.81e-05 | 191 | 102 | 5 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.81e-05 | 191 | 102 | 5 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.81e-05 | 191 | 102 | 5 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.00e-05 | 192 | 102 | 5 | 8df4cfe1461819756138ff1180896238dca2787e | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.00e-05 | 192 | 102 | 5 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.00e-05 | 192 | 102 | 5 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 8.00e-05 | 192 | 102 | 5 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 8.20e-05 | 193 | 102 | 5 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.40e-05 | 194 | 102 | 5 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.40e-05 | 194 | 102 | 5 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | PBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.40e-05 | 194 | 102 | 5 | 5a519538327029ad2b880ef9647e2ac6ab3961a4 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 8.61e-05 | 195 | 102 | 5 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-MMP9+_Inflammatory_macrophage|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.61e-05 | 195 | 102 | 5 | 5a7c74f96f213c504abd65e751800da7e03e47d9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.82e-05 | 196 | 102 | 5 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | wk_08-11-Epithelial-PNS-TM4SF4+_PENK+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.82e-05 | 196 | 102 | 5 | afa3a2f5f3a51d1830c6f95f97a4b3e13ed42512 | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.82e-05 | 196 | 102 | 5 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | FLU-Healthy-2|FLU / Virus stimulation, Condition and Cluster | 8.82e-05 | 196 | 102 | 5 | 0f2240a64a1cdd3147f2330f51c871cd0df8c055 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.03e-05 | 197 | 102 | 5 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Severe|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 9.03e-05 | 197 | 102 | 5 | df3f58b58f82c42c65b0a09c054b669b34502037 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.03e-05 | 197 | 102 | 5 | eb07545bef5ad506fbbe3a1f99131f26c1447a31 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 9.03e-05 | 197 | 102 | 5 | a97556e9fbb24272de51f54ecda6ab9ccb97a61e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.03e-05 | 197 | 102 | 5 | 280804810041783f1b7704914b62ffefbb0d88f6 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B-GC_B_(I)|GI_large-bowel / Manually curated celltypes from each tissue | 9.03e-05 | 197 | 102 | 5 | 80a0cfbd454409594effead7082586b06c2f411a | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 9.25e-05 | 198 | 102 | 5 | e84c5f712e1dea548d0e2aba6625598f9671d3a0 | |
| ToppCell | distal-mesenchymal-Myofibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.25e-05 | 198 | 102 | 5 | beef5075ba6dcd4d0a447bc4e57efcaf2e93c546 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.25e-05 | 198 | 102 | 5 | 93cc01d91ffc543fd1a717ef47e02e532b50b665 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.25e-05 | 198 | 102 | 5 | 641e7be258303bb9782d19fcf8693f317581d3b8 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.25e-05 | 198 | 102 | 5 | 2d8d4eb21b4fe3cc178b3518b3ea39c2d9650f24 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 9.47e-05 | 199 | 102 | 5 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 9.47e-05 | 199 | 102 | 5 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.47e-05 | 199 | 102 | 5 | b827dd8a249f904a0ff930a6c4d3b00fb7bc6fb1 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 9.47e-05 | 199 | 102 | 5 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.47e-05 | 199 | 102 | 5 | c0dcdda30485bb920d3706dcfb06f11b76b6ea37 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.47e-05 | 199 | 102 | 5 | c40cb51c738b15d2761a50cfc8415a31a673be7f | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.47e-05 | 199 | 102 | 5 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.47e-05 | 199 | 102 | 5 | 655d07cf9a2fd9b945a2ed4f824cba0297de72a8 | |
| ToppCell | tumor_Lung-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 9.69e-05 | 200 | 102 | 5 | 58ff8db0ecf71daa86f9a38208e0d9b712cac0b5 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.69e-05 | 200 | 102 | 5 | 9e8659bbc6547f1ab7f4e0a81b0bcbe158e9e2f7 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.69e-05 | 200 | 102 | 5 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | Mild-Myeloid-Macrophages-FCN1-SPP1+|Mild / Condition, Lineage, Cell class and cell subclass | 9.69e-05 | 200 | 102 | 5 | e5afd8e2cb2c63899d49fe17011f474d20bb06ea | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-05 | 200 | 102 | 5 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgG_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | 9.69e-05 | 200 | 102 | 5 | fee909730133ec9875e14f7deed2a351dd21dba4 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-05 | 200 | 102 | 5 | 49ad6e2337886367fbfa2a7c7366687b701ddf39 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 9.69e-05 | 200 | 102 | 5 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-T/NK_proliferative|Leuk-UTI / Disease, condition lineage and cell class | 9.69e-05 | 200 | 102 | 5 | 093e97395be23092229521cc55aaaee8befbc149 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-7|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.08e-04 | 127 | 102 | 4 | 5e4d110cc6e68cd8fc7a4771a65e6f8cd83e7721 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Esm1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.34e-04 | 131 | 102 | 4 | 3cb4b272e28ee9bad6d874f64a7aae18352a6cfb | |
| ToppCell | ASK452-Epithelial-Secretory|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.41e-04 | 132 | 102 | 4 | 49ba24e24b3127b5257a88a0ee0246c9843c580a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.48e-04 | 133 | 102 | 4 | 840e8240db29cd21ed9830843c0fa6d65b8f300a | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Sphkap-Excitatory_Neuron.Gad1Gad2.Sphkap-Cpne4_(Basomedial_amygdaloid_nucleus_(BMA))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.58e-04 | 54 | 102 | 3 | 7670a6eb185ae0d8c3c0cb17f8eaa9970355187b | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Sphkap-Excitatory_Neuron.Gad1Gad2.Sphkap-Cpne4_(Basomedial_amygdaloid_nucleus_(BMA))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.58e-04 | 54 | 102 | 3 | 79f804e73f859c0e8192d9e9e6ee2282f7f1691b | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Sphkap|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.87e-04 | 56 | 102 | 3 | af55596513ddbe60b08648b27e41a7b65e3da58c | |
| ToppCell | Healthy-CD4+_T_activated|World / disease group, cell group and cell class | 3.01e-04 | 140 | 102 | 4 | 407691970ec72a3afb45e431cf48814546b8acff | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.35e-04 | 144 | 102 | 4 | 04f9054895be2275eecda687a6eeb02fa5ec69b9 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_interstitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.44e-04 | 145 | 102 | 4 | 778655fffd73df101e656154a41b478a1b695116 | |
| ToppCell | Healthy-CD4+_T_activated|Healthy / disease group, cell group and cell class | 3.44e-04 | 145 | 102 | 4 | 45e8089fdf7d6f69b383816d8945e39fba24c873 | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Mast-Mast_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.53e-04 | 146 | 102 | 4 | a5c84ad44d6ffb25028a4fd5454fd5de81b16a5e | |
| Drug | 2 6a | 3.15e-06 | 23 | 102 | 4 | CID010062690 | |
| Drug | NSC169490 | 6.16e-06 | 27 | 102 | 4 | CID004210613 | |
| Disease | complex cortical dysplasia with other brain malformations 4 (implicated_via_orthology) | 1.11e-05 | 2 | 99 | 2 | DOID:0090138 (implicated_via_orthology) | |
| Disease | mitochondrial complex V (ATP synthase) deficiency (implicated_via_orthology) | 3.34e-05 | 3 | 99 | 2 | DOID:0111143 (implicated_via_orthology) | |
| Disease | major depressive disorder (implicated_via_orthology) | 3.34e-05 | 3 | 99 | 2 | DOID:1470 (implicated_via_orthology) | |
| Disease | 4-hydroxyhippurate measurement | 6.66e-05 | 4 | 99 | 2 | EFO_0021508 | |
| Disease | Mental Retardation, X-Linked 1 | 1.69e-04 | 32 | 99 | 3 | C2931498 | |
| Disease | Mood Disorders | 2.62e-04 | 168 | 99 | 5 | C0525045 | |
| Disease | dystonia (implicated_via_orthology) | 7.20e-04 | 12 | 99 | 2 | DOID:543 (implicated_via_orthology) | |
| Disease | esophageal adenocarcinoma, digestive system disease, Barrett's esophagus | 1.65e-03 | 18 | 99 | 2 | EFO_0000280, EFO_0000405, EFO_0000478 | |
| Disease | psoriasis, type 2 diabetes mellitus | 2.08e-03 | 75 | 99 | 3 | EFO_0000676, MONDO_0005148 | |
| Disease | anxiety disorder (implicated_via_orthology) | 2.46e-03 | 22 | 99 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | Sarcosine measurement | 2.69e-03 | 23 | 99 | 2 | EFO_0021668 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AYTQLKLSGLLPSAY | 1051 | Q8WWZ7 | |
| PQDTKVLQYYFNLGL | 976 | Q9NP73 | |
| QQLVYSAGVYRLPKN | 806 | Q9UJX6 | |
| YGTLLNAINLYKNTP | 871 | O43683 | |
| LAAQYQSLLNSYGEP | 311 | O00429 | |
| LYLPKFSISRDYNLN | 311 | P01011 | |
| KDYQPNYFLSIPITN | 81 | Q9P0M2 | |
| KPALRSGVQQLIQYY | 246 | Q13790 | |
| NYLALKTADGQYLLN | 731 | Q9UP79 | |
| LFLKNQLGTGYYLTL | 1116 | O95477 | |
| TEGSKQLLNNYPVYI | 381 | Q6ZU67 | |
| SGINPLVYTLFNKIY | 361 | P28335 | |
| GYARNPSLKQQLFSY | 101 | Q06055 | |
| NKSKVINLSQYGPAY | 1491 | Q8TDJ6 | |
| PSLIGLKQYYKVVNS | 271 | Q9UHI6 | |
| LISKLNSYYGNVPVI | 221 | Q7L7V1 | |
| GYARNPSLKQQLFSY | 96 | P05496 | |
| FLYYQSQELPNGSVK | 336 | Q5T2W1 | |
| FQPQQLSTYALTLYK | 46 | Q9UBK7 | |
| FQPQQLSTYALTLYK | 46 | Q9UNT1 | |
| NQSLSLLYKVPYVAQ | 541 | Q06481 | |
| KYKLQQTFSVNPIYL | 321 | P19113 | |
| KSQLLQYVYNLVPRG | 516 | P33991 | |
| KNPNIVNYLDSYLVG | 336 | O75914 | |
| GKSLYINSGNIPDYL | 581 | Q9NPP4 | |
| PLVAKLAAYAQYQAT | 111 | Q05BQ5 | |
| AYQILNSYKPQASLS | 471 | Q14703 | |
| YNNGNYTLIAKNPLG | 371 | Q16288 | |
| ALLEKIPSDYNLGNY | 1226 | Q96NW7 | |
| QTAFPALQLKYLYLN | 161 | Q6UXM1 | |
| NNYITGTNPLKLGYI | 2681 | O43451 | |
| LPSKQGYYLQGNYLR | 3076 | Q2LD37 | |
| AVALNYGIYKQDLPS | 176 | Q92598 | |
| QSLLILNKTNFTYYP | 1126 | Q9HCM2 | |
| GNSLKLYTINPNQYF | 161 | Q9Y5G3 | |
| KLGQYSLALDYINAA | 386 | Q6N069 | |
| GSNLSALPLYNLYNK | 256 | A2RU54 | |
| LGYANSALNPILYAA | 276 | P25021 | |
| LTPAQQYSLRAKYAA | 881 | P10070 | |
| SYGYLLPAKNSKQDQ | 256 | O95371 | |
| LKYCPLNGGQQSLYR | 111 | P60321 | |
| AALAVLGPQTLQYSY | 436 | Q9UHF4 | |
| NKGTFLRLYYPSQDN | 76 | Q13093 | |
| TKLQLNYLGNYIPRF | 246 | Q02809 | |
| NSPTPYKIQYNGLTL | 1061 | Q13332 | |
| GDPAIYQSLKAQNAY | 156 | Q9UJ42 | |
| AASTYLNNPYVRKAL | 336 | P10619 | |
| LKTIYYTGPNENLLA | 591 | Q86VX9 | |
| LPNPLLTYQLYGKFS | 396 | O14559 | |
| IQLDGLPAAQKLVYY | 296 | Q8N878 | |
| KFNIIASLYDYNPNL | 376 | B5ME19 | |
| QKSQYLQLGPSRGQY | 46 | Q6UUV9 | |
| SQLIRAGKPYQLQIY | 821 | Q86TI2 | |
| LQNYQLAYSKAYPRL | 41 | Q9Y6R7 | |
| AYQLYSLGLIDKPNL | 506 | Q92562 | |
| KFGYNAYLSNQLPLN | 146 | Q9NY28 | |
| LKYSDQPNILFYLNT | 856 | A8TX70 | |
| YFIAKNLIQSAYNLP | 231 | P30550 | |
| QAGLYSISLPNKYNF | 196 | Q6Y1H2 | |
| KSQYSLYLNSISNQP | 181 | A2RUB6 | |
| SNSLLNPVIYAYFNK | 391 | P08908 | |
| PGNYILKVSVNPSYL | 371 | P28300 | |
| QLLATNPPYSLFYKS | 246 | Q9H819 | |
| TDTNLYFQPLNGYPK | 216 | Q92636 | |
| SFNELYPSGTLKLQY | 1541 | Q8WYP5 | |
| QLIRGKANYSLQIYP | 806 | P42658 | |
| LLPKQLGQYFRYNGS | 201 | Q9ULX7 | |
| QASYLPKPGAQLYQF | 86 | Q9P1Z2 | |
| DYIFYSKPQLNTLGI | 491 | Q9ULM6 | |
| PLLAEAYSNLGNVYK | 86 | O15294 | |
| YTNKNGSFANLRIYP | 51 | P52788 | |
| SYALLFGDYLPQNIQ | 226 | Q9UBV2 | |
| NLKNSLKQLTDPYYL | 441 | Q7LBE3 | |
| SLPALKELYASYNNI | 136 | Q8IYG6 | |
| YLNYLRKLNVSTGLP | 591 | Q96NR3 | |
| AGLLEYLNPNYKDAT | 1341 | Q8IVG5 | |
| LASQSGQPLAIYYLA | 436 | Q5TEA6 | |
| ATNYIYTPLNQLKGG | 6 | Q9NUX5 | |
| YSLLDPSYAKNNIPI | 331 | P46977 | |
| NPSILEKYYNNLLTI | 211 | O43173 | |
| TELYLYSNKLQSLPA | 126 | Q9UQ13 | |
| YNSLNDSFKRLIYPL | 486 | Q8N5C6 | |
| AQLPPKYQLGSTSYL | 336 | Q9UPG8 | |
| LLYGLYNTQLCQPKQ | 81 | Q16533 | |
| NGLSIYVFLQPYKKS | 56 | Q9NS75 | |
| LLQQYKTLAYPFQSL | 261 | Q96Q45 | |
| SPVGSKLAYVYQNNI | 156 | Q12884 | |
| LYIDSIPKTLGNLYN | 776 | Q7Z2Z1 | |
| LQASGYQPDLSYNLA | 181 | Q8N4P2 | |
| ALLPNITLGYQLYDV | 91 | Q7RTX1 | |
| SILNSPYAKLYNPEN | 76 | P23258 | |
| PNFYSKNLLLLGKTY | 256 | Q96DB5 | |
| QAIAYSLLAGLQPIY | 86 | Q9H2B4 | |
| SSNKYGLDYLKNQPA | 1256 | Q6ZV73 | |
| ASYLNYKLQAPLSEP | 146 | Q6NUQ4 | |
| YQLLNSGLSKSIYPA | 281 | Q3MJ13 | |
| NYGQAPLSLLVSYTK | 166 | P02774 | |
| NYKNLVSLGYQLTKP | 46 | P21506 | |
| APLQYSLLLQYLVGD | 21 | Q9Y584 | |
| LQASGYQPDLSYNLA | 181 | Q86WT1 | |
| SILNSPYAKLYNPEN | 76 | Q9NRH3 | |
| NNFLITGPKAYLTYT | 26 | Q9H1J5 | |
| VCLYINKQANAGPYL | 96 | Q8N228 | |
| NLLLGYKNPDQVYLA | 171 | Q86Y07 | |
| KNFLSLNYLAEYLQP | 201 | Q03167 |